Published in Respiratory Therapeutics Week, March 17th, 2008
"Indeed, this disturbed neurohormonal balance can be at least partly restored by adrenergic beta-receptor blockers, angiotensin-conversion inhibitors and receptor blockers, and aldosterone antagonists, with beneficial functional and prognostic effects. Right...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.